| Sofinnova Partners. (3/3/21). "Press Release: Sofinnova Partners Closes €445M ($540M) Oversubscribed Late-stage Healthcare Crossover Fund". Paris. |
2021-03-03 |
| Dotmatics Ltd.. (3/3/21). "Press Release: Dotmatics Announces Licensing Agreement for Informatics Software with Compugen". Bishop’s Stortford. |
2021-03-03 |
| LGC. (3/3/21). "Press Release: LGC Acquires Paragon Scientific, Strengthening Its Position in Reference Materials". London. |
2021-03-03 |
| TrakCel Ltd.. (3/3/21). "Press Release: TrakCel Fuels Growth and Increased Market Access Through Strategic Investment Round". Cardiff. |
2021-03-03 |
| ERS Genomics Ltd.. (3/3/21). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to Otsuka Pharmaceutical". Dublin. |
2021-03-03 |
| ERS Genomics Ltd.. (3/1/21). "Press Release: ERS Genomics Expands Team With Appointment of Jon Kratochvil as VP Business Development". Dublin. |
2021-03-01 |
| Oxular Ltd.. (3/1/21). "Press Release: Oxular Raises $37 Million". Oxford. |
2021-03-01 |
| Nabriva Therapeutics plc. (2/26/21). "Press Release: Nabriva Therapeutics Appoints Daniel Dolan as Chief Financial Officer". Dublin & King of Prussia, PA. |
2021-02-26 |
| Coulter Partners. (2/25/21). "Press Release: Coulter Partners Announces New Appointments in London, the US and Germany". |
2021-02-25 |
| Aptum Biologics Ltd.. (2/24/21). "Press Release: New Features of EpiQuest Suite Software (v4)". Southampton. |
2021-02-24 |
| Resolve Biosciences GmbH. (2/22/21). "Press Release: Resolve Biosciences Announces Initial Results from Early Access Collaborations with Scientists Leading the Next Generation of Subcellular Spatial Analysis". Monheim am Rhein. |
2021-02-22 |
| Immunocore Holdings plc. (2/19/21). "Press Release: Immunocore’s Tebentafusp Granted Breakthrough Therapy Designation for Unresectable or Metastatic Uveal Melanoma from FDA". Oxfordshire, Conshohocken, PA & Rockville, MD. |
2021-02-19 |
| Evox Therapeutics Ltd.. (2/18/21). "Press Release: Evox Therapeutics Completes £69.2 Million Series C Financing". |
2021-02-18 |
| Charles River Laboratories International, Inc.. (2/17/21). "Press Release: Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development". Wilmington, MA. |
2021-02-17 |
| ERS Genomics Ltd.. (2/16/21). "Press Release: ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement". Dublin & Barcelona. |
2021-02-16 |
| Centessa Pharmaceuticals Ltd.. (2/16/21). "Press Release: Centessa Pharmaceuticals Launches with $250 Million Series A Financing and Unveils a New Kind of Pharmaceutical R&D Model". Cambridge, MA & London. |
2021-02-16 |
| Immunocore Holdings plc. (2/16/21). "Press Release: Immunocore Announces Key Appointments to Management and Board". Oxfordshire & Conshohocken, PA. |
2021-02-16 |
| Discovery Park Ltd.. (2/15/21). "Press Release: Fast Growing Food Safety Testing Firm Curtis Analytics Relocates to Discovery Park". Sandwich, Kent. |
2021-02-15 |
| Rentschler Biopharma SE. (2/11/21). "Press Release: Rentschler Biopharma Establishes Center of Excellence for Cell and Gene Therapy in the UK". Laupheim & Stevenage. |
2021-02-11 |
| Quell Therapeutics Ltd.. (2/11/21). "Press Release: Quell Therapeutics Expands Series A Financing to $84 Million". London. |
2021-02-11 |
| Rentschler Biopharma SE. (2/11/21). "Press Release: Rentschler Biopharma to Build New Cell and Gene Therapy Capabilities in the UK". London & Laupheim. |
2021-02-11 |
| SpyBiotech Ltd.. (2/10/21). "Press Release: SpyBiotech Raises $32.5M in Series A funding and Appoints Lutz B. Giebel as Chairman". Oxford. |
2021-02-10 |
| Immunocore Holdings plc. (2/9/21). "Press Release: Immunocore Announces Closing of $312.1 Million Aggregate Financing, Consisting of $297.1 Million Initial Public Offering, Full Exercise of Option to Purchase Additional ADSs and $15.0 Million Concurrent |
2021-02-09 |
| Secarna Pharmaceuticals GmbH & Co. KG. (2/4/21). "Press Release: Secarna Pharmaceuticals Appoints Alexander Gebauer, MD, PhD as CEO and Managing Director". Munich/Martinsried. |
2021-02-04 |
| PepGen Ltd.. (2/4/21). "Press Release: PepGen Announces Appointment of James McArthur, Ph.D., as President and Chief Executive Officer". Boston, MA & Oxford. |
2021-02-04 |
| Abingworth LLP. (2/3/21). "Press Release: Abingworth Raises $465m for New Life Sciences Fund Abingworth Bioventures 8". London. |
2021-02-03 |
| GlaxoSmithKline plc. (2/3/21). "Press Release: GSK and CureVac to Develop Next Generation mRNA COVID-19 Vaccines". London, Tübingen & Boston, MA. |
2021-02-03 |
| Almirall S.A.. (2/3/21). "Press Release: Almirall Announces Gianfranco Nazzi as New CEO". |
2021-02-03 |
| Jazz Pharmaceuticals plc. (2/3/21). "Press Release: Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader". Dublin & London. |
2021-02-03 |
| BioPartner UK. (2/2/21). "Press Release: BioPartner Appoints Paul Clewlow as New Advisory Board Member". |
2021-02-02 |
| Cytiva. (2/1/21). "Press Release: Cytiva Acquires Vanrx Pharmasystems, Canadian Aseptic Filling Innovator". Amersham. |
2021-02-01 |
| Horizon Therapeutics plc. (2/1/21). "Press Release: Horizon Therapeutics plc to Acquire Viela Bio, Inc. to Significantly Expand Development Pipeline and Grow Rare Disease Medicine Portfolio". Dublin & Gaithersburg, MD. |
2021-02-01 |
| Exact Therapeutics AS. (1/29/21). "Press Release: Exact Therapeutics Announces Change of CFO with Departure of Stig Jarle Pettersen at the End of His Contracted Period". Oslo & London. |
2021-01-29 |
| Piper Sandler Companies. (1/28/21). "Press Release: Piper Sandler Expands European Healthcare Investment Banking with the Hiring of Vincenzo di Nicola". New York, NY. |
2021-01-28 |
| Avacta Group plc. (1/28/21). "Press Release: Avacta Announces Collaboration Agreement with Bruker". Cambridge, Wetherby & Billerica, MA. |
2021-01-28 |
| Exact Therapeutics AS. (1/26/21). "Press Release: Exact Therapeutics Announces Appointment of Dr Hilary McElwaine-Johnn as Chief Medical Officer and Opening of London Office". Oslo & London. |
2021-01-26 |
| Minoryx Therapeutics S.L.. (1/26/21). "Press Release: Minoryx Presents Topline Results from Phase 2/3 »ADVANCE« Study Demonstrating Significant Clinical Benefit of Leriglitazone in Adrenomyeloneuropathy (AMN)". Mataró, Barcelona. |
2021-01-26 |
| MiNA Therapeutics Ltd.. (1/21/21). "Press Release: Servier and MiNA Therapeutics Enter Collaboration in Neurological Diseases". Paris & London. |
2021-01-21 |
| BiondVax Pharmaceuticals Ltd.. (1/21/21). "Press Release: BiondVax Announces Appointment of Amir Reichman as New CEO". Jerusalem. |
2021-01-21 |
| Life Sciences Partners (LSP). (1/20/21). "Press Release: LSP Leads EUR 21 Million Series B Funding Round in Neurent Medical". Amsterdam. |
2021-01-20 |
| Slate Bio, Inc.. (1/19/21). "Press Release: Slate Bio Launches with Seed Financing to Develop Next Generation IL-2 Therapies". Charlottesville, VA. |
2021-01-19 |
| ConserV Bioscience Ltd.. (1/19/21). "Press Release: ConserV Bioscience and Lawrence Livermore National Laboratory to Collaborate on Development of Broad-spectrum Coronavirus Vaccine". London & Livermore, CA. |
2021-01-19 |
| Lonza Group AG. (1/19/21). "Press Release: NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms". Basel & London. |
2021-01-19 |
| Cognate Bioservices, Inc.. (1/14/21). "Press Release: Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe". Memphis, TN. |
2021-01-14 |
| IO Biotech ApS. (1/13/21). "Press Release: IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncology". Copenhagen. |
2021-01-13 |
| Boehringer Ingelheim. (1/12/21). "Press Release: Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies". Ingelheim, Oxford & London. |
2021-01-12 |
| Creoptix AG. (1/12/21). "Press Release: Domainex Invests in the Creoptix WAVEdelta to Strengthen Its Fragment-based Drug Discovery Platform. Strong Partnership Ahead". Wädenswil & Saffron Walden. |
2021-01-12 |
| Life Sciences Partners (LSP). (1/12/21). "Press Release: LSP and Philip Scheltens Launch New, Unique Fund to Fight Dementia". Amsterdam. |
2021-01-12 |
| Affimed N.V.. (1/11/21). "Press Release: Affimed Announces €25 Million Debt Financing Agreement with Silicon Valley Bank". Heidelberg. |
2021-01-11 |
| Sanofi S.A.. (1/11/21). "Press Release: Sanofi to Acquire Kymab, Adding KY1005 to Its Pipeline, a Human Monoclonal Antibody Targeting Key Immune System Regulator OX40L". Paris & Cambridge. |
2021-01-11 |
| Novartis AG. (1/11/21). "Press Release: Novartis Expands Oncology Pipeline with In-licensing of Tislelizumab from BeiGene". Basel. |
2021-01-11 |
| Immunocore Ltd.. (1/11/21). "Press Release: Immunocore Announces Closing of $75.0 Million Series C Round". Oxfordshire, Conshohocken, PA & Rockville, MD. |
2021-01-11 |
| Qiagen N.V.. (1/7/21). "Press Release: Qiagen Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute". Redwood City, CA & Hilden. |
2021-01-07 |
| BioGeneration Ventures B.V.. (1/7/21). "Press Release: BioGeneration Ventures BGV IV Fund Closes at €140 Million". Naarden. |
2021-01-07 |
| Advicenne S.A.. (1/7/21). "Press Release: Advicenne Announces the Appointment of Peter Meeus as Chief Executive Officer". Paris. |
2021-01-07 |
| Merus N.V.. (1/7/21). "Press Release: Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers". Utrecht & Cambridge, MA. |
2021-01-07 |
| PerkinElmer, Inc.. (1/7/21). "Press Release: PerkinElmer to Acquire Oxford Immunotec Global plc". Waltham, MA & London. |
2021-01-07 |
| Moderna, Inc.. (1/6/21). "Press Release: European Commission Authorizes COVID-19 Vaccine Moderna in Europe". Cambridge, MA. |
2021-01-06 |
| Satorius AG. (1/6/21). "Press Release: Sartorius to Acquire Novasep’s Chromatography Process Equipment Division". Göttingen. |
2021-01-06 |
| Gilead Sciences, Inc.. (1/6/21). "Press Release: Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors". Santa Monica, CA, Oxford & San Jose, CA. |
2021-01-06 |
| MiNA Therapeutics Ltd.. (1/5/21). "Press Release: MiNA Therapeutics Appoints Robin Wright as Chief Financial Officer". London. |
2021-01-05 |
| University of Birmingham. (1/5/21). "Press Release: New COVID-19 Test Gives Positive Result in Just a Few Minutes". |
2021-01-05 |
| Novacyt S.A.. (1/5/21). "Press Release: Executive Management and Proposed Board Changes". Paris & Camberley. |
2021-01-05 |
| Faron Pharmaceuticals Oy. (1/4/21). "Press Release: Faron to Present at H.C. Wainwright BioConnect". Turku. |
2021-01-04 |
| Clinigen Group plc. (1/4/21). "Press Release: Clinigen Appoints Sam Herbert as Chief Operating Officer". |
2021-01-04 |
| AstraZeneca plc. (12/30/20). "Press Release: AstraZeneca’s COVID-19 Vaccine Authorised for Emergency Supply in the UK". |
2020-12-30 |
| Peptilogics. (12/21/20). "Press Release: Peptilogics Closes $35.4 Million Series B Financing to Further Advance Proprietary Computational Peptide Drug Design and Discovery Platform". Pittsburgh, PA. |
2020-12-21 |
| Uniqure N.V.. (12/21/20). "Press Release: uniQure Announces Clinical Update on Hemophilia B Gene Therapy Program". Lexington, MA & Amsterdam. |
2020-12-21 |
| NuCana plc. (12/21/20). "Press Release: NuCana Appoints Andrew Kay as Board Chairman". Edinburgh. |
2020-12-21 |
| GlaxoSmithKline plc. (12/18/20). "Press Release: GSK and Ahren Announce Co-Led Series A Investment in Adrestia, and Multi-Project Discovery Collaboration with Each of the Five Projects Eligible To Receive Up To $230M (£172M) in Post Option Milestones". L |
2020-12-18 |
| InnoSkel S.A.S.. (12/14/20). "Press Release: InnoSkel Launches with €20 Million Series A Financing". Copenhagen. |
2020-12-14 |
| AstraZeneca plc. (12/12/20). "Press Release: AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development [Not for any jurisdicition where violation of relevant laws]". |
2020-12-12 |
| Nouscom AG. (12/11/20). "Press Release: Nouscom Appoints Göran Ando MD as Chairman and Richard Davis PhD as Chief Business Officer". Basel. |
2020-12-11 |
| NanoSyrinx Ltd.. (12/10/20). "Press Release: NanoSyrinx Strengthens Board with Appointment of Dr Jane Dancer as Non-Executive Director". Coventry. |
2020-12-10 |
| [iito] Business Intelligence. (12/10/20). "The [LSE] Newsletter Is Out! Hand-picked & Manually Edited European and Israeli Life Science Business News". Bremen. |
2020-12-10 |
| Enara Bio Ltd.. (12/9/20). "Press Release: Enara Bio Relocates to The Oxford Science Park’s Newest Facility to Expand R&D Capabilities in the Search for Novel Vancer Immunotherapies". Oxford & London. |
2020-12-09 |
| PepGen Ltd.. (12/9/20). "Press Release: PepGen Raises $45M Series A". Boston, MA & Oxford. |
2020-12-09 |
| Forbion Capital Partners. (12/8/20). "Press Release: Forbion Secures EUR 460 Million for Oversubscribed Fifth Fund". Naarden & Munich. |
2020-12-08 |
| Achilles Therapeutics Ltd.. (12/7/20). "Press Release: Achilles Therapeutics Appoints Lee M. Stern as VP, IR & External Communications". Stevenage. |
2020-12-07 |
| CureVac N.V.. (12/4/20). "Press Release: CureVac Appoints Antony Blanc as Chief Business Officer and Chief Commercial Officer". Tübingen & Boston, MA. |
2020-12-04 |
| Transgene S.A.. (12/3/20). "Press Release: Transgene Appoints Hedi Ben Brahim as Chairman and Chief Executive Officer". Strasbourg. |
2020-12-03 |
| University of Edinburgh, Centre for Regenerative Medicine. (12/2/20). "Press Release: Cell Therapy Spinout Targets Liver Repair Treatment". |
2020-12-02 |
| Syncona Ltd.. (12/2/20). "Press Release: Resolution Therapeutics Announces a £26.6m Series A Financing from Syncona Ltd". |
2020-12-02 |
| BioInnovation Institute (BII). (12/2/20). "Press Release: BioInnovation Institute Takes in New Cohort of Promising Early-stage Innovations". Copenhagen. |
2020-12-02 |
| ERS Genomics Ltd.. (12/1/20). "Press Release: Vivlion GmbH Signs Worldwide License Agreement With ERS Genomics for CRISPR/Cas9 Patent Portfolio". Dublin & Frankfurt/M.. |
2020-12-01 |
| Salesforce.com Inc.. (12/1/20). "Press Release: Salesforce Signs Definitive Agreement to Acquire Slack". San Francisco, CA. |
2020-12-01 |
| Achilles Therapeutics Ltd.. (12/1/20). "Press Release: Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer". Stevenage. |
2020-12-01 |
| [iito] Business Intelligence. (11/30/20). "The [LSG] Newsletter Is Out! Hand-picked & Manually Edited DACH Region Life Science Business News from Germany, Austria & Switzerland". Bremen. |
2020-11-30 |
| BioNTech SE. (11/25/20). "Press Release: BioNTech and InstaDeep Announce Strategic Collaboration and Form AI Innovation Lab to Develop Novel Immunotherapies". Mainz & London. |
2020-11-25 |
| LGC. (11/25/20). "Press Release: LGC Offers Regulated Bioanalysis on the Sciex TripleTOF 6600 High-Resolution Mass Spectrometry Platform". London. |
2020-11-25 |
| ATAI Life Sciences AG. (11/23/20). "Press Release: ATAI Life Sciences Announces Closing of $125 Million Series C Financing Round". New York, NY. |
2020-11-23 |
| Catamaran Bio, Inc.. (11/23/20). "Press Release: Catamaran Bio Launches with $42 Million Financing to Develop Off-the-Shelf CAR-NK Cell Therapies to Treat Solid Tumors". Cambridge, MA. |
2020-11-23 |
| Omnix Medical. (11/20/20). "Press Release: Omnix Medical Announces Successful $8.5 Million Funding Round". |
2020-11-20 |
| SynOx Therapeutics Ltd.. (11/19/20). "Press Release: SynOx Therapeutics Raises €37M in Series A Financing. HealthCap and Medicxi Co-lead, Joined by Forbion and Gimv". Dublin. |
2020-11-19 |
| SR One Capital Management. (11/19/20). "Press Release: SR One Completes Spin-out from GSK and Closes First Fund at $500 Million". San Francisco, CA & London. |
2020-11-19 |
| MeiraGTx Holdings plc. (11/19/20). "Press Release: MeiraGTx Announces Pricing of Public Offering of Ordinary Shares". London & New York, NY. |
2020-11-19 |
| Achilles Therapeutics Ltd.. (11/19/20). "Press Release: Achilles Therapeutics Raises £52.7 Million in an Oversubscribed Series C Financing to Further Advance the Development of Personalised T cell Therapies to Treat Solid Tumours". Stevenage. |
2020-11-19 |
| Emergex Vaccines Holding Ltd.. (11/18/20). "Press Release: Emergex Vaccines Raises US$11 Million to Advance Pipeline of Synthetic T-Cell Vaccines for Infectious Diseases". Abingdon. |
2020-11-18 |
| Evotec SE. (11/17/20). "Press Release: Evotec and Storm Therapeutics Leverage INDiGO Platform to Progress Oncology Project towards Clinical Studies". Hamburg. |
2020-11-17 |
| Myricx Pharma Ltd.. (11/16/20). "Press Release: Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer". Stevenage. |
2020-11-16 |
![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo-2019.png){kind=logo}
Date
![Picture [iito] Back into Ad 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-back-into-ad.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
